Amidst the intricate and global landscape of pharmaceutical industry operations, the significance of international regulatory alignment for drug development has grown significantly. The pharmaceutical sector operates on a worldwide scale with diverse characteristics, making it imperative to streamline regulatory standards. Various regulatory bodies often impose distinct scientific and administrative criteria that drug manufacturers must adhere to for product approval. This divergence can result in redundant efforts, heightened expenses, extended timelines for product launches, and delayed patient accessibility.

To confront this challenge, the FDA collaborates with regulatory bodies and industry stakeholders across the globe to unify regulatory requirements spanning different regions. One pivotal aspect of the FDA’s pursuit of regulatory harmony is its role as a Founding Regulatory Member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).

In a recent conversation with Theresa Mullin, PhD, Associate Center Director for CDER’s Strategic Initiatives, CDER’s significant contributions within ICH are examined. This includes assuming leadership roles in key committees and expert working groups, the development of standardized guidelines and associated training programs, and offering expert insights during the guideline formulation process.1

Read more here.

References

  1. Research, C. F. D. E. A. (2023). FDA works through ICH to support global drug development: creating harmonized technical standards through guidelines. U.S. Food And Drug Administration. https://www.fda.gov/drugs/news-events-human-drugs/fda-works-through-ich-support-global-drug-development-creating-harmonized-technical-standards

Disclaimers

  • The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
  • Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
  • No official support by any organization(s) has been provided or should be inferred